• This record comes from PubMed

COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study

. 2022 ; 10 () : 938067. [epub] 20220725

Language English Country Switzerland Media electronic-ecollection

Document type Journal Article, Research Support, Non-U.S. Gov't

Since healthcare professionals (HCPs) play a critical role in shaping their local communities' attitudes toward vaccines, HCPs' beliefs and attitudes toward vaccination are of vital importance for primary prevention strategies. The present study was designed as a cross-sectional survey-based study utilizing a self-administered questionnaire to collect data about COVID-19 vaccine booster hesitancy (VBH) among Polish HCPs and students of medical universities (MUSs). Out of the 443 included participants, 76.3% were females, 52.6% were HCPs, 31.8% were previously infected by SARS-CoV-2, and 69.3% had already received COVID-19 vaccine booster doses (VBD). Overall, 74.5% of the participants were willing to receive COVID-19 VBD, while 7.9 and 17.6% exhibited their hesitance and rejection, respectively. The most commonly found promoter for acceptance was protection of one's health (95.2%), followed by protection of family's health (81.8%) and protection of community's health (63.3%). Inferential statistics did not show a significant association between COVID-19 VBH and demographic variables, e.g., age and gender; however, the participants who had been previously infected by SARS-CoV-2 were significantly more inclined to reject the VBD. Protection from severe infection, community transmission, good safety profile, and favorable risk-benefit ratio were the significant determinants of the COVID-19 VBD acceptance and uptake. Fear of post-vaccination side effects was one of the key barriers for accepting COVID-19 VBD, which is consistent with the pre-existing literature. Public health campaigns need to highlight the postulated benefits of vaccines and the expected harms of skipping VBD.

See more in PubMed

Kadkhoda K. Herd immunity to COVID-19: alluring and elusive. Am J Clin Pathol. (2021) 155:471–2. 10.1093/ajcp/aqaa272 PubMed DOI PMC

Randolph HE, Barreiro LB. Herd immunity: understanding COVID-19. Immunity. (2020) 52:737–41. 10.1016/j.immuni.2020.04.012 PubMed DOI PMC

Ritchie H, Edouard M, Lucas R-G, Cameron A, Charlie G, Esteban O-O, et al. . Coronavirus pandemic (COVID-19). Our World Data. (2022). Available online at: https://ourworldindata.org/coronavirus (accessed April 27, 2022).

Stay Up to Date With Your COVID-19 Vaccines. Centers Disease Control and Prevention; (2022). Available online at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html (accessed April 27, 2022).

Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, et al. . Waning immune humoral response to BNT162b2 COVID-19 vaccine over 6 months. N Engl J Med. (2021) 385:e84. 10.1056/NEJMoa2114583 PubMed DOI PMC

Chemaitelly H, Tang P, Hasan MR, AlMukdad S, Yassine HM, Benslimane FM, et al. . Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N Engl J Med. (2021) 385:e83. 10.1056/NEJMoa2114114 PubMed DOI PMC

Aleem A, Akbar Samad AB, Slenker AK. Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19). Treasure Island, FL: StatPearls Publishing. PubMed

Chenchula S, Karunakaran P, Sharma S, Chavan M. Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: a systematic review. J Med Virol. (2022) 94:2969–76. 10.1002/jmv.27697 PubMed DOI PMC

Zdrowia M,. Komunikat nr 12 Ministra Zdrowia w sprawie szczepień przeciw COVID-19 dawka przypominajaca oraz dawka dodatkowa uzupełniajaca schemat podstawowy. Serwis Rzeczyposp Pol. (2021). Available online at: https://www.gov.pl/web/zdrowie/komunikat-nr-12-ministra-zdrowia-w-sprawie-szczepien-przeciw-covid-19-dawka-przypominajaca-oraz-dawka-dodatkowa-uzupelniajaca-schemat-podstawowy (accessed April 27, 2022).

The Chancellery of the Prime Minister. Prime Minister After Receiving a Booster Dose of the Vaccination: ”Getting vaccinated is the Best Gift We Can Give to Ourselves and Our Loved ones." Website Repub Pol (2021). Available online at: https://www.gov.pl/web/primeminister/prime-minister-after-receiving-a-booster-dose-of-the-vaccination-getting-vaccinated-is-the-best-gift-we-can-give-to-ourselves-and-our-loved-ones (accessed April 27, 2022).

Ministerstwo, Zdrowia,. Druga dawka przypominajaca dla osób 80+. Serwis Rzeczyposp Pol. Available online at: https://www.gov.pl/web/zdrowie/druga-dawka-przypominajaca-dla-osob-80 (accessed April 27, 2022).

Szczepienie przeciwko COVID-19. Raport szczepień przeciwko COVID-19. Serwis Rzeczyposp Pol. Available online at: https://www.gov.pl/web/szczepimysie/raport-szczepien-przeciwko-covid-19 (accessed April 27, 2022).

Rzymski P, Poniedziałek B, Fal A. Willingness to receive the booster COVID-19 vaccine dose in Poland. Vaccines. (2021) 9:1286. 10.3390/vaccines9111286 PubMed DOI PMC

Babicki M, Mastalerz-Migas A. Attitudes of poles towards the COVID-19 vaccine booster dose: an online survey in Poland. Vaccines. (2022) 10:68. 10.3390/vaccines10010068 PubMed DOI PMC

MacDonald NE, Eskola J, Liang X, Chaudhuri M, Dube E, Gellin B, et al. . Vaccine hesitancy: definition, scope and determinants. Vaccine. (2015) 33:4161–4. 10.1016/j.vaccine.2015.04.036 PubMed DOI

Strategic Advisory Group of Experts on Immunization (SAGE). Report of the Sage Working Group on Vaccine Hesitancy. (2014). Available online at: https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf (accessed October 1, 2021).

Rosselli R, Martini M, Bragazzi NL. The old and the new: vaccine hesitancy in the era of the Web 2.0. Challenges and opportunities. J Prev Med Hyg. (2016) 57:E47. PubMed PMC

Riad A, Huang Y, Abdulqader H, Morgado M, Domnori S, Koščík M, et al. . Universal predictors of dental students' attitudes towards COVID-19 vaccination: machine learning-based approach. Vaccines. (2021) 9:1158. 10.3390/vaccines9101158 PubMed DOI PMC

Riad A, Abdulqader H, Morgado M, Domnori S, Koščík M, Mendes JJ, et al. . Global prevalence and drivers of dental students' COVID-19 vaccine hesitancy. Vaccines. (2021) 9:566. 10.3390/vaccines9060566 PubMed DOI PMC

Oberg EB, Frank E. Physicians' health practices strongly influence patient health practices. J R Coll Physicians Edinb. (2009) 39:290–1. 10.4997/JRCPE.2009.422 PubMed DOI PMC

Klugar M, Riad A, Mohanan L, Pokorná A. COVID-19 vaccine booster hesitancy (VBH) of healthcare workers in Czechia: national cross-sectional study. Vaccines. (2021) 9:1437. 10.3390/vaccines9121437 PubMed DOI PMC

Harvard Humanitarian Initiative,. Welcome to KoBoToolbox. KoBoToolbox Doc. (2022). Available online at: https://support.kobotoolbox.org/welcome.html (accessed January 4, 2022).

Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. UroToday Int J. (2007) 335:806–8. 10.1136/bmj.39335.541782.AD PubMed DOI PMC

English Proficiency Index 2021. Education First (2021). Available online at: https://www.ef.com/wwen/epi/ (accessed January 12, 2022).

Centers for Disease Control Prevention (CDC). Population Survey or Descriptive Study. StatCalc | User Guide. Available online at: https://www.cdc.gov/epiinfo/user-guide/statcalc/samplesize.html (accessed December 1, 2021).

Attia S, Mausbach K, Klugar M, Howaldt H-P, Riad A. Prevalence and drivers of COVID-19 vaccine booster hesitancy (VBH) among German University Students and Employees. Front Public Heal. (2012) 10:846861. 10.3389/fpubh.2022.846861 PubMed DOI PMC

WMA . World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. (2013) 310:2191–4. 10.1001/jama.2013.281053 PubMed DOI

Proton Technologies AG,. General Data Protection Regulation (GDPR) Compliance Guidelines. Horiz 2020 - Proj REP-791727-1. (2020). Available online at: https://gdpr.eu/ (accessed May 1, 2020).

SPSS Inc,. IBM SPSS Statistics 28. (2021). Available online at: https://www.ibm.com/support/pages/ibm-spss-statistics-28-documentation (accessed March 14, 2021).

The jamovi project . jamovi (Version 1.6) [Computer Software]. (2021). Available online at: https://www.jamovi.org (accessed February 11, 2022).

Massimi A, Voglino G, Gualano MR, Chee Koh SW, Tan HM, Lee WH, et al. . COVID-19 vaccine booster hesitancy among healthcare workers: a retrospective observational study in Singapore. Vaccines. (2022) 10:464. 10.3390/vaccines10030464 PubMed DOI PMC

Batra K, Yoshida M, Kobashi Y, Kawamura T, Shimazu Y, Nishikawa Y, et al. . Factors associated with COVID-19 vaccine booster hesitancy: a retrospective cohort study, Fukushima vaccination community survey. Vaccines. (2022) 10:515. 10.3390/vaccines10040515 PubMed DOI PMC

Pal S, Shekhar R, Kottewar S, Upadhyay S, Singh M, Pathak D, et al. . COVID-19 vaccine hesitancy and attitude toward booster doses among US healthcare workers. Vaccines. (2021) 9:1358. 10.3390/vaccines9111358 PubMed DOI PMC

Folcarelli L, Del Giudice GM, Corea F, Angelillo IF. Intention to receive the COVID-19 vaccine booster dose in a university community in Italy. Vaccines. (2022) 10:146. 10.3390/vaccines10020146 PubMed DOI PMC

Lounis M, Bencherit D, Rais MA, Riad A. COVID-19 vaccine booster hesitancy (VBH) and its drivers in algeria: national cross-sectional survey-based study. Vaccines. (2022) 10:621. 10.3390/vaccines10040621 PubMed DOI PMC

Hu T, Li L, Lin C, Yang Z, Chow C, Lu Z, et al. . An analysis of the willingness to the COVID-19 vaccine booster shots among urban employees: evidence from a megacity H in Eastern China. Int J Environ Res Public Health. (2022) 19:2300. 10.3390/ijerph19042300 PubMed DOI PMC

Al-Qerem W, Al Bawab AQ, Hammad A, Ling J, Alasmari F. Willingness of the Jordanian population to receive a COVID-19 booster dose: a cross-sectional study. Vaccines. (2022) 10:410. 10.3390/vaccines10030410 PubMed DOI PMC

Yadete T, Batra K, Netski DM, Antonio S, Patros MJ, Bester JC. Assessing acceptability of COVID-19 vaccine booster dose among adult Americans: a cross-sectional study. Vaccines. (2021) 9:1424. 10.3390/vaccines9121424 PubMed DOI PMC

Wong MCS, Wong ELY, Huang J, Cheung AWL, Law K, Chong MKC, et al. . Acceptance of the COVID-19 vaccine based on the health belief model: a population-based survey in Hong Kong. Vaccine. (2021) 39:1148–56. 10.1016/j.vaccine.2020.12.083 PubMed DOI PMC

Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccines Immunother. (2020) 16:2204–14. 10.1080/21645515.2020.1790279 PubMed DOI PMC

Shmueli L. Predicting intention to receive COVID-19 vaccine among the general population using the health belief model and the theory of planned behavior model. BMC Public Health. (2021) 21:804. 10.1186/s12889-021-10816-7 PubMed DOI PMC

Eurostat . Majority of health jobs held by women. Products Eurostat News. (2021). Available online at: https://ec.europa.eu/eurostat/web/products-eurostat-news/-/edn-20210308-1 (accessed May 2, 2022).

Organisation for Economic Co-operation and Development (OECD) . Young women are better educated than young men, but gender gaps in labour market outcomes persist. Closing Gender Gap. Available online at: https://www.oecd.org/gender/Closing the Gender Gap - Poland FINAL.pdf (accessed May 2, 2022).

Statista . Poland - average age of the population 1950-2050. Economic and Politics. Available online at: https://www.statista.com/statistics/375688/average-age-of-the-population-in-poland/ (accessed May 2, 2022).

Małgorzata Omyła-Rudzka,. Efekty uboczne szczepień przeciw COVID-19 - doświadczenia respondentów. Public Opinion Research Centre (2021). Available online at: https://www.cbos.pl/SPISKOM.POL/2021/K_081_21.PDF (accessed May 2, 2022).

Dziedzic A, Riad A, Attia S, Klugar M, Tanasiewicz M. Self-reported adverse events of COVID-19 vaccines in polish healthcare workers and medical students. Cross-sectional study and pooled analysis of CoVaST project results in Central Europe. J Clin Med. (2021) 10:5338. 10.3390/jcm10225338 PubMed DOI PMC

World Health Organization (WHO). WHO Coronavirus Dashboard With Vaccine Data. Available online at: https://covid19.who.int/region/euro/country/pl (accessed May 2, 2022).

Kuter BJ, Browne S, Momplaisir FM, Feemster KA, Shen AK, Green-McKenzie J, et al. . Perspectives on the receipt of a COVID-19 vaccine: a survey of employees in two large hospitals in Philadelphia. Vaccine. (2021) 39:1693–700. 10.1016/j.vaccine.2021.02.029 PubMed DOI PMC

Rabi R, Maraqa B, Nazzal Z, Zink T. Factors affecting nurses' intention to accept the COVID-19 vaccine: a cross-sectional study. Public Health Nurs. (2021) 38:781–8. 10.1111/phn.12907 PubMed DOI PMC

Szmyd B, Karuga FF, Bartoszek A, Staniecka K, Siwecka N, Bartoszek A, et al. . Attitude and behaviors towards SARS-CoV-2 vaccination among healthcare workers: a cross-sectional study from Poland. Vaccines. (2021) 9:218. 10.3390/vaccines9030218 PubMed DOI PMC

Riad A, Schünemann H, Attia S, Peričić TP, Žuljević MF, Jürisson M, et al. . COVID-19 vaccines safety tracking (CoVaST): protocol of a multi-center prospective cohort study for active surveillance of COVID-19 vaccines' side effects. Int J Environ Res Public Heal. (2021) 18:7859. 10.3390/ijerph18157859 PubMed DOI PMC

Lounis M, Rais MA, Bencherit D, Aouissi HA, Oudjedi A, Klugarová J, et al. . Side effects of COVID-19 inactivated virus versus adenoviral vector vaccines: experience of Algerian healthcare workers. Front Public Heal. (2022) 10:896343. 10.3389/fpubh.2022.896343 PubMed DOI PMC

Riad A, Hocková B, Kantorová L, Slávik R, Spurná L, Stebel A, et al. . Side effects of mRNA-based COVID-19 vaccine: nationwide phase IV study among healthcare workers in Slovakia. Pharmaceuticals. (2021) 14:873. 10.3390/ph14090873 PubMed DOI PMC

Klugar M, Riad A, Mekhemar M, Conrad J, Buchbender M, Howaldt H-P, et al. . Side effects of mRNA-based and viral vector-based COVID-19 vaccines among German Healthcare Workers. Biology. (2021) 10:752. 10.3390/biology10080752 PubMed DOI PMC

Riad A, Sagiroglu D, Üstün B, Pokorná A, Klugarová J, Attia S, Klugar M. Prevalence and risk factors of CoronaVac side effects: an independent cross-sectional study among healthcare workers in Turkey. J Clin Med. (2021) 10:2629. 10.3390/jcm10122629 PubMed DOI PMC

Youssef D, Abou-Abbas L, Berry A, Youssef J, Hassan H. Determinants of acceptance of Coronavirus disease-2019 (COVID-19) vaccine among Lebanese health care workers using health belief model. PLoS ONE. (2022) 17:e0264128. 10.1371/journal.pone.0264128 PubMed DOI PMC

Larson HJ, Jarrett C, Schulz WS, Chaudhuri M, Zhou Y, Dube E, et al. . Measuring vaccine hesitancy: the development of a survey tool. Vaccine. (2015) 33:4165–75. 10.1016/j.vaccine.2015.04.037 PubMed DOI

Bar-On Bar-On YM. Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Kalkstein N, et al. . Protection of BNT162b2 vaccine booster against COVID-19 in Israel. N Engl J Med. (2021) 385:1393–400. 10.1056/NEJMoa2114255 PubMed DOI PMC

Qin C, Wang R, Tao L, Liu M, Liu J. Association between risk perception and acceptance for a booster dose of COVID-19 vaccine to children among child caregivers in China. Front Public Heal. (2022) 10:514. 10.3389/fpubh.2022.834572 PubMed DOI PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...